Supreme Court to hear challenge to Myriad gene patents, Bloomberg reports The U.S. Supreme Court agreed to consider a challenge to Myriad Genetics' (MYGN) and other biotechnology companies' right to be granted patents on human genes, reported Bloomberg. Reference Link
News For MYGN From The Last 14 Days
Check below for free stories on MYGN the last two weeks.